                       SECURITIES AND EXCHANGE COMMISSION

                              Washington, DC 20549

                                   ----------

                                    FORM 8-K

                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                Date of Report (Date of earliest event reported):
                                  June 3, 2003

                           CORNICHE GROUP INCORPORATED
             (Exact name of registrant as specified in its charter)

                                    Delaware
                 (State or other jurisdiction of incorporation)

        0-10909                                                  22-2343568
Commission File Number                                          IRS Employer
                                                              Identification No.

        330 South Service Road, Suite 120, Melville, New York        11747
               (Address of principal executive offices)           (Zip Code)

                                  631-574-4955
                          Registrant's Telephone Number

<PAGE>

ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE

      Corniche  Group  Incorporated  (the  "Company")  issued the press  release
annexed hereto  announcing  the  appointment of Dr. Wayne Marasco as a member of
the Board of Directors.

      To secure Dr. Marasco's  service as a director,  the Company,  pursuant to
its newly  adopted  2003 Equity  Participation  Plan,  the  Company  granted Dr.
Marasco  the right and  option,  exercisable  for 10 years,  to  purchase  up to
300,000  shares of the Company's  common stock at an exercise price of $0.05 per
share. In addition,  in the event that the closing price of the Company's common
stock  equals or exceeds  $0.50 per share for any five (5)  consecutive  trading
days  during  his term as a  director,  the  Company  has agreed to grant to Dr.
Marasco  an option  for the  purchase  of an  additional  100,000  shares of the
Company's common stock for an exercise price of $0.50 per share. Dr. Marasco has
agreed that he will not resell publicly any shares of the Company's common stock
obtained upon exercise of either of these options prior to the first anniversary
of the date of his election to the board.

      The Company intends to call a meeting of stockholders on or about July 11,
2003 to, among other matters:  (1) elect two directors  (including Dr.  Marasco)
and (2) to ratify the Company's 2003 Equity  Participation  Plan,  including the
grant thereunder to Dr. Marasco.

                                    * * * * *

      This Report contains forward-looking  statements made pursuant to the safe
harbor  provisions  of the  Private  Securities  Litigation  Reform Act of 1995.
Forward-looking  statements  represent  management's  judgment  regarding future
events.  Although  management  believes that the expectations  reflected in such
statements are reasonable,  they give no assurance that such  expectations  will
prove to be correct and you should be aware that  actual  results  could  differ
materially  from those  contained  in the  forward-looking  statements  due to a
number of factors.  These  factors  include  the risk that the  Company  will be
unable to raise capital,  to enter successfully or exploit  opportunities in the
biotech  or  medical  business,  to have  appropriate  personnel,  or the  risks
inherent in any new business  venture or those  detailed in the Company's  other
reports  filed  with  the  Securities  and  Exchange  Commission.   The  Company
undertakes no obligation to update or revise the  information  contained in this
Report whether as a result of new information, future events or circumstances or
otherwise.

ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS

Exhibit 99.1      Press Release

<PAGE>

                                    SIGNATURE

      Pursuant to the  requirements of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                       CORNICHE GROUP INCORPORATED

                                       By: /s/ Mark Weinreb
                                           ---------------------------------
                                           Mark Weinreb
                                           President

Dated: June 4, 2003

